KZR vs GILD: Which Stock is Better?

Side-by-side comparison of Kezar Life Sciences Inc and Gilead Sciences Inc in 2026

Comparison Updated:

KZR

Kezar Life Sciences Inc

$7.33

GILD

Gilead Sciences Inc

$137.64

Key Metrics Comparison

MetricKZRGILDWinner
Market Cap$54.33M$171.97BGILD
P/E RatioN/A20.44GILD
EPS (TTM)$N/A$6.78GILD
Revenue Growth0.0%0.0%GILD
Gross Margin0.0%78.8%GILD

Analyze KZR

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is KZR or GILD a better investment?

Comparing KZR and GILD: Kezar Life Sciences Inc has a market cap of $54.33M while Gilead Sciences Inc has $171.97B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between KZR and GILD?

KZR (Kezar Life Sciences Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: KZR or GILD?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: KZR or GILD?

GILD has higher revenue growth at 0.0% vs 0.0% for KZR.

Which company is more profitable: KZR or GILD?

Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for KZR.

Which is the larger company: KZR or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $171.97B compared to $54.33M for KZR.

Should I buy KZR or GILD in 2026?

Both KZR and GILD have investment merit. KZR trades at $7.33 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between KZR and GILD stock?

Key differences: Market Cap ($54.33M vs $171.97B), P/E Ratio (N/A vs 20.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).

Popular Stock Comparisons